Irbesartan-Hydrochlorothiazide Articles

Teva debuts generic of Provigil, Avapro and Avalide; Ranbaxy Crestor copy OKed in Canada

1 April 2012

Pharmacopeia intitiates Ph IIb trial of DARA drug

10 March 2008

FDA clears Avalide as initial high BP therapy

26 November 2007

Continued rebound of Plavix lifts Bristol-Myers Squibb's third quarter

5 November 2007

B-MS' 2nd-qtr income up 5.8% on Plavix resurgence; future cost cuts planned

6 August 2007

Bristol-Myers Squibb's 1st-qtr sales and profits down, as takeover talk continues

7 May 2007

B-MS swings to loss in 4th qtr due to Plavix

5 February 2007

Bristol-Myers Squibb's 3rd-qtr income down 65% to $388M, as sales fall 12.5%

6 November 2006

B-MS's earnings hit $714M in 1st-qtr

8 May 2006

One-time tax benefit drives Bristol-Myers Squibb 2nd-qtr profits up 90%

8 August 2005

DTB questions antihypertensives as first-line therapy for diabetes 2

13 June 2005

Bristol-Myers Squibb reports 16% fall in 3rd-qtr earnings, though sales rise 1%

8 November 2004

20% pharma sales rise boosts B-MS profits

9 February 2004

Sanofi-Synthelabo sales up 9% in 3rd quarter

1 November 1999

EC approves Sanofi's Coaprovel

22 October 1998

Showing 1-15 of 15 articles

Go to beginningPrevious
  • 1
NextGo to end